Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain

被引:150
作者
Licastro, F
Grimaldi, LME
Bonafè, M
Martina, C
Olivieri, F
Cavallone, L
Giovanietti, S
Masliah, E
Franceschi, C
机构
[1] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
[2] Dept Neurosci, Caltanisetta, Italy
[3] INRCA Res Dept, Ancona, Italy
[4] Univ Calif San Diego, Dept Neurosci & Pathol, San Diego, CA 92103 USA
关键词
Alzheimer's disease risk; IL-6; gene; blood and brain IL-6 levels;
D O I
10.1016/S0197-4580(03)00013-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Two different polymorphic regions of the interleukin-6 (IL-6) gene were investigated in patients with Alzheimer's disease (AD) and non-demented controls. The - 174 C allele in the promoter region of IL-6 gene was over-represented in AD patients compared to controls and significantly increased the risk of AD. Moreover, the - 174 CC genotype was associated with a high risk of the disease in women. The D allele of a variable number of tandem repeat (VNTR) was in strong linkage disequilibrium with the - 174 C allele and slightly increased AD risk. On the other hand, the frequency of the VNTR C allele was decreased in patients with AD and was negatively associated with the risk of developing AD. Both the - 174 CC and VNTR DD genotypes were also associated with increased IL-6 levels in the blood and brain from AD. These findings suggest that IL-6 may play a multifaceted role in AD by affecting the turnover of the cytokine. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:921 / 926
页数:6
相关论文
共 39 条
[31]   GLIAL CYTOKINES IN ALZHEIMERS-DISEASE - REVIEW AND PATHOGENIC IMPLICATIONS [J].
MRAK, RE ;
SHENG, JG ;
GRIFFIN, WST .
HUMAN PATHOLOGY, 1995, 26 (08) :816-823
[32]  
Papassotiropoulos A, 1999, ANN NEUROL, V45, P666, DOI 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO
[33]  
2-3
[34]   APOLIPOPROTEIN-E POLYMORPHISM AND ALZHEIMERS-DISEASE [J].
POIRIER, J ;
DAVIGNON, J ;
BOUTHILLIER, D ;
KOGAN, S ;
BERTRAND, P ;
GAUTHIER, S .
LANCET, 1993, 342 (8873) :697-699
[35]   The genetics of Alzheimer's disease [J].
Rubinsztein, DC .
PROGRESS IN NEUROBIOLOGY, 1997, 52 (06) :447-454
[36]  
STRAUSS S, 1992, LAB INVEST, V66, P223
[37]   Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576 [J].
Tehranian, R ;
Hasanvan, H ;
Iverfeldt, K ;
Post, C ;
Schultzberg, M .
NEUROSCIENCE LETTERS, 2001, 301 (01) :54-58
[38]   Effects of IL6 and IL1β on aFGF expression and excitotoxicity in NT2N cells [J].
Thorns, V ;
Walter, GF ;
Licastro, F .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 127 (1-2) :22-29
[39]   DECREASED INTERLEUKIN-6 LEVEL IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA [J].
YAMADA, K ;
KONO, K ;
UMEGAKI, H ;
YAMADA, K ;
IGUCHI, A ;
FUKATSU, T ;
NAKASHIMA, N ;
NISHIWAKI, H ;
SHIMADA, Y ;
SUGITA, Y ;
YAMAMOTO, T ;
HASEGAWA, T ;
NABESHIMA, T .
NEUROSCIENCE LETTERS, 1995, 186 (2-3) :219-221